The stock of SeaStar Medical Holding Corp (ICU) has seen a -23.42% decrease in the past week, with a 5.59% gain in the past month, and a -16.26% decrease in the past quarter. The volatility ratio for the week is 13.17%, and the volatility levels for the past 30 days are at 10.91% for ICU. The simple moving average for the past 20 days is -14.61% for ICU’s stock, with a -57.20% simple moving average for the past 200 days.
Is It Worth Investing in SeaStar Medical Holding Corp (NASDAQ: ICU) Right Now?
ICU has 36-month beta value of -1.07. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ICU is 8.50M, and currently, short sellers hold a 3.94% ratio of that float. The average trading volume of ICU on March 31, 2025 was 405.09K shares.
ICU) stock’s latest price update
The stock price of SeaStar Medical Holding Corp (NASDAQ: ICU) has dropped by -22.73 compared to previous close of 2.20. Despite this, the company has seen a fall of -23.42% in its stock price over the last five trading days. globenewswire.com reported 2025-03-27 that DENVER, March 27, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today financial results for the three months and year ended December 31, 2024, and provided business updates on key initiatives. “Our significant accomplishment in 2024 position us well for a transformational year in 2025,” said Eric Schlorff, SeaStar Medical CEO.
ICU Trading at -8.92% from the 50-Day Moving Average
After a stumble in the market that brought ICU to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.79% of loss for the given period.
Volatility was left at 10.91%, however, over the last 30 days, the volatility rate increased by 13.17%, as shares sank -1.73% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.08% lower at present.
During the last 5 trading sessions, ICU fell by -23.42%, which changed the moving average for the period of 200-days by -59.62% in comparison to the 20-day moving average, which settled at $1.9909. In addition, SeaStar Medical Holding Corp saw -12.37% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ICU starting from Neuman John, who purchase 10,000 shares at the price of $5.24 back on Aug 15 ’24. After this action, Neuman John now owns 30,000 shares of SeaStar Medical Holding Corp, valued at $52,396 using the latest closing price.
Neuman John, the Director of SeaStar Medical Holding Corp, purchase 10,000 shares at $4.35 during a trade that took place back on Jun 17 ’24, which means that Neuman John is holding 20,000 shares at $43,521 based on the most recent closing price.
Stock Fundamentals for ICU
Current profitability levels for the company are sitting at:
- -132.16 for the present operating margin
- 1.0 for the gross margin
The net margin for SeaStar Medical Holding Corp stands at -183.93. The total capital return value is set at 8.17.
Based on SeaStar Medical Holding Corp (ICU), the company’s capital structure generated -0.36 points at debt to capital in total, while cash flow to debt ratio is standing at -27.52. The debt to equity ratio resting at -0.26. The interest coverage ratio of the stock is -35.9.
Currently, EBITDA for the company is -17.84 million with net debt to EBITDA at 0.05. When we switch over and look at the enterprise to sales, we see a ratio of 100.56. The receivables turnover for the company is 1.21for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.55.
Conclusion
To put it simply, SeaStar Medical Holding Corp (ICU) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
